The trademark application ADRAMIX was filed by ADAMED PHARMA S.A., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on July 30, 2024, and still open for oppositions.
The application was filed in English (German was selected as the second language).